Elevaate Biotech, inc. Is a non-profit organization dedicated to furthering east Asian American leadership of the biotech and pharmaceutical industries. Elevaate works to strengthen networks of senior and mid-career east Asian Americans in biopharma and to empower current east Asian American leaders, and mentor and train rising executives.
Main program · fiscal year 2024
Elevaate Biotech, inc. Elevaate is a non-profit organization dedicated to furthering east Asian American leadership of the biotech and pharmaceutical industries. Elevaate works to strengthen networks of senior and mid-career east Asian Americans in biopharma and to empower current east Asian American leaders, and mentor and train rising executives.$71,980 spent
Where each dollar went · fiscal year 2024
Of every dollar it spent, 45¢ went to programs, 50¢ to management and 5¢ to fundraising.
Programs $71,980
Management $80,920
Fundraising $8,568
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$475,036Fiscal year 2024
Expenses$161,468Fiscal year 2024
Total assets$344,705Fiscal year 2024
Total liabilities$31,137Fiscal year 2024
Fiscal year ending December2024
Revenue$475,036
Expenses$161,468
Net income$313,568
Net assets$313,568
Notable sources of revenue
Percent of total revenue
Contributions
$475,000
100.0%
Program services
$0
0.0%
Investment income
$36
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$344,705
Total liabilities
$31,137
Net assets
$313,568
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?